These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 32893721)
1. Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Martinez-Gili L; McDonald JAK; Liu Z; Kao D; Allegretti JR; Monaghan TM; Barker GF; Miguéns Blanco J; Williams HRT; Holmes E; Thursz MR; Marchesi JR; Mullish BH Gut Microbes; 2020 Nov; 12(1):1810531. PubMed ID: 32893721 [TBL] [Abstract][Full Text] [Related]
2. Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Mullish BH; McDonald JAK; Pechlivanis A; Allegretti JR; Kao D; Barker GF; Kapila D; Petrof EO; Joyce SA; Gahan CGM; Glegola-Madejska I; Williams HRT; Holmes E; Clarke TB; Thursz MR; Marchesi JR Gut; 2019 Oct; 68(10):1791-1800. PubMed ID: 30816855 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiome and plasma lipidome analysis reveals a specific impact of Arcay R; Barceló-Nicolau M; Suárez L; Martín L; Reigada R; Höring M; Liebisch G; Garrido C; Cabot G; Vílchez H; Cortés-Lara S; González de Herrero E; López-Causapé C; Oliver A; Barceló-Coblijn G; Mena A mBio; 2024 Oct; 15(10):e0134724. PubMed ID: 39189787 [TBL] [Abstract][Full Text] [Related]
4. Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway. Monaghan T; Mullish BH; Patterson J; Wong GK; Marchesi JR; Xu H; Jilani T; Kao D Gut Microbes; 2019; 10(2):142-148. PubMed ID: 30183484 [TBL] [Abstract][Full Text] [Related]
5. Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile). Minkoff NZ; Aslam S; Medina M; Tanner-Smith EE; Zackular JP; Acra S; Nicholson MR; Imdad A Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013871. PubMed ID: 37096495 [TBL] [Abstract][Full Text] [Related]
6. Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. Seekatz AM; Theriot CM; Rao K; Chang YM; Freeman AE; Kao JY; Young VB Anaerobe; 2018 Oct; 53():64-73. PubMed ID: 29654837 [TBL] [Abstract][Full Text] [Related]
7. Bile acids impact the microbiota, host, and McMillan AS; Theriot CM Gut Microbes; 2024; 16(1):2393766. PubMed ID: 39224076 [No Abstract] [Full Text] [Related]
8. Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection. Brown JR; Flemer B; Joyce SA; Zulquernain A; Sheehan D; Shanahan F; O'Toole PW BMC Gastroenterol; 2018 Aug; 18(1):131. PubMed ID: 30153805 [TBL] [Abstract][Full Text] [Related]
10. Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Khanna S; Vazquez-Baeza Y; González A; Weiss S; Schmidt B; Muñiz-Pedrogo DA; Rainey JF; Kammer P; Nelson H; Sadowsky M; Khoruts A; Farrugia SL; Knight R; Pardi DS; Kashyap PC Microbiome; 2017 May; 5(1):55. PubMed ID: 28506317 [TBL] [Abstract][Full Text] [Related]
11. Longitudinal Bile Acid Composition Changes Following Faecal Microbiota Transplantation for Clostridioides difficile Infection in Children With and Without Underlying Inflammatory Bowel Disease. Chen LA; Oliva-Hemker M; Radin A; Weidner M; O'Laughlin BD; Sears CL; Javitt NB; Hourigan SK J Crohns Colitis; 2023 Aug; 17(8):1364-1368. PubMed ID: 36988432 [TBL] [Abstract][Full Text] [Related]
12. Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile. Kumar R; Maynard CL; Eipers P; Goldsmith KT; Ptacek T; Grubbs JA; Dixon P; Howard D; Crossman DK; Crowley MR; Benjamin WH; Lefkowitz EJ; Weaver CT; Rodriguez JM; Morrow CD BMC Microbiol; 2016 Jan; 16():5. PubMed ID: 26758906 [TBL] [Abstract][Full Text] [Related]
13. Fecal microbiota transplantation for treatment of patients with recurrent Voth E; Khanna S Expert Rev Anti Infect Ther; 2020 Jul; 18(7):669-676. PubMed ID: 32266848 [TBL] [Abstract][Full Text] [Related]
18. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection. Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663 [TBL] [Abstract][Full Text] [Related]
19. The evaluation of fecal microbiota transplantation vs vancomycin in a Clostridioides difficile infection model. Xu Q; Zhang S; Quan J; Wu Z; Gu S; Chen Y; Zheng B; Lv L; Li L Appl Microbiol Biotechnol; 2022 Oct; 106(19-20):6689-6700. PubMed ID: 36085529 [TBL] [Abstract][Full Text] [Related]
20. Recovery of the gut microbiome following fecal microbiota transplantation. Seekatz AM; Aas J; Gessert CE; Rubin TA; Saman DM; Bakken JS; Young VB mBio; 2014 Jun; 5(3):e00893-14. PubMed ID: 24939885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]